Perseverance
Precision
Impact
Rewiring the future of oncology by targeting core lineage dependencies.
At CORE Biomedicine, we are redefining precision oncology — developing next-generation cancer therapeutics that go beyond genomic alterations to address the fundamental biological programs driving tumor survival and progression.
Mission
CORE Biomedicine is a preclinical-stage oncology company dedicated to innovating precision medicine therapeutics by targeting core lineage-dependent pathways in cancer.
Traditional genomics-centric approaches capture only part of what sustains tumors. We are committed to unlocking the deeper biology that governs cancer identity and therapy resistance — and to translating those insights into life-changing medicines.
Vision
We envision a world where every cancer patient benefits from therapies tailored not just to mutations, but to the biological essence of their disease — delivering more effective, durable outcomes for large populations of cancer patients.
